Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
- 22 February 2010
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 125 (6), 511-512
- https://doi.org/10.1016/j.thromres.2009.09.019
Abstract
No abstract availableKeywords
Funding Information
- University of North Carolina Wilmington
This publication has 19 references indexed in Scilit:
- D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis StudyJournal of Clinical Oncology, 2009
- Microparticle-associated tissue factor activity in cancer patients with and without thrombosisJournal of Thrombosis and Haemostasis, 2009
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancerJournal of Thrombosis and Haemostasis, 2008
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)Blood, 2008
- Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007
- Tissue factor expression as a possible determinant of thromboembolism in ovarian cancerBritish Journal of Cancer, 2007
- Procoagulant MicroparticlesArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Risk factors for venous thromboembolic events in cancer patientsAnnals of Oncology, 2005
- Elevation of Endothelial Microparticles, Platelets, and Leukocyte Activation in Patients With Venous ThromboembolismJournal of the American College of Cardiology, 2005